Britain fines drugmakers $360 million for overcharging NHS

Britain's competition regulator said on Thursday it has fined several drugmakers a total of more than 260 million pounds ($360 million) for overcharging the state-backed NHS healthcare network for hydrocortisone tablets for almost a decade.

The Competition and Markets Authority said it has fined Accord-UK, Auden Mckenzie, Allergan Plc, Accord Healthcare, Intas Pharmaceuticals, Way made Plc, Amdipharm, Advanz Pharma Services, and some Cinven entities. ($1 = 0.7219 pounds)

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)